gpc-100
Generic: CXCR4 Inhibitor GPC-100·Code: GPC-100
gpc-100: 1 clinical trial tracked.
gpc-100 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about gpc-100, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Phase 2, Randomized, Open-Label Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Primary endpoint: Proportion of patients that achieve >=2 x 10^6 CD34+ cells/kg in 2 leukapheresis sessions
InterventionalRandomizedopen30 enrolledStarted 2023-02Completion 2025-1010 sites · United StatesGPCR Therapeutics, Inc.